Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia
JAMA Network Open · 11.08.2025 · 8 (8) · e2526129
DOI: 10.1001/jamanetworkopen.2025.26129 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 11.08.2025. Verfasst von Lucía Fernández-Romero und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute, Universidad Complutense de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Aphasia, Primary Progressive, Language Therapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance Primary progressive aphasia (PPA) is a neurodegenerative clinical syndrome with no effective treatment.
Objective
To evaluate the efficacy, safety, and adherence of transcranial magnetic stimulation (TMS) plus language therapy in participants with PPA over 6 months. Design, Setting, and Participants This prospective, double-blind parallel-design randomized clinical trial was performed in Spain between December 2021 and July 2024. Participants meeting criteria for PPA and with a Clinical Dementia Rating of 0 to 1 (in which scores range from 0 to 3, with higher scores indicating greater severity of dementia symptoms) were eligible.
Interventions
Participants were randomized 2:1 to active-TMS (intermittent theta-burst TMS protocol) vs sham-TMS therapy for 6 months, immediately followed by evidence-based language intervention for treating PPA, stratified by PPA variants (nonfluent/agrammatic, semantic, and logopenic). Main Outcomes and Measures The main outcome was the standardized uptake value ratio in a large brain region encompassing most of the left hemisphere, assessed at baseline and at 6 months (immediately following the intervention) and measured by 18 F-fludeoxyglucose–positron emission tomography. Secondary outcomes included results from the Mini Linguistic State Examination, confrontation naming, words per minute derived from a spontaneous speech task, the Interview for Deterioration in Daily Living Activities in Dementia, and the Neuropsychiatric Inventory. Secondary outcomes were assessed at baseline, 3 months, and 6 months. Safety and adherence were also evaluated.
Results
Among 78 participants who were screened for the study, 63 were enrolled (mean [SD] age, 71.8 [8.4] years; 42 females [66.7%]); of these, 42 were randomized to the active-TMS group and 21 were randomized to the sham-TMS group. The primary outcome measure was positive; the adjusted mean of the standardized uptake value ratio at 6 months was higher in the active group than in the sham group (0.78 [95% CI, 0.77-0.79] vs 0.77 [95% CI, 0.75-0.78]; P = .046). Active TMS was associated with improvement in the mean adjusted difference for all of the secondary outcomes at 6 months (Mini Linguistic State Examination: 7.71 [95% CI, 3.06-12.35], confrontation naming: 23.81 [95% CI, 11.85-35.77], Interview for Deterioration in Daily Living Activities in Dementia: −5.39 [95% CI, −10.73 to −0.05], and Neuropsychiatric Inventory: −4.25 [95% CI, −8.37 to −0.14]), except for words per minute results (3.41 [95% CI, −8.86 to 15.68]). There were no significant differences in the number of adverse events. Adherence was complete in 58 of 63 participants (92.1%). Conclusions and Relevance In this randomized clinical trial including participants with PPA, intermittent theta-burst TMS over the left dorsolateral prefrontal cortex during a 6-month interval was associated with less decline in regional brain metabolism and improvement in language abilities, functional independence, and neuropsychiatric symptoms. These findings suggest that TMS combined with evidence-based language intervention in participants with PPA promotes greater functional outcomes and slower progression compared with language therapy alone. Trial Registration ClinicalTrials.gov Identifier: NCT05842473
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute, Universidad Complutense de Madrid, Madrid, Spain.
- Department of Nuclear Medicine, Hospital Clínico San Carlos, San Carlos Health Research Institute, Universidad Complutense de Madrid, Madrid, Spain.
- Faculty of Psychology, University of Oviedo, Oviedo, Spain.
- Department of Speech, Language, and Hearing Sciences, The University of Texas at Austin.
- Department of Pharmacology and Toxicology, Universidad Complutense de Madrid, Madrid, Spain.
- Unidad de Investigación Clínica y Ensayos Clínicos, Instituto de Investigacion Sanitaria Hospital Clinico San Carlos, Madrid, Spain.
Förderung
- NIA NIH HHS
Zitieren
APA
Fernández-Romero, L., Cabrera-Martin, M. N., Delgado-Alonso, C., Suárez-Coalla, P., Grasso, S. M., Portolés, A., Pérez-Macías, N., Carreras, M. T., Díez-Cirarda, M., Gil-Moreno, M. J., Olazarán, J., Vieira, A., Oliver-Mas, S., Gómez-Pinedo, U., Matías-Guiu, J., & Matias-Guiu, J. A. (2025). Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia. JAMA Network Open, 8(8), e2526129. https://doi.org/10.1001/jamanetworkopen.2025.26129
Vancouver
Fernández-Romero L, Cabrera-Martin MN, Delgado-Alonso C, Suárez-Coalla P, Grasso SM, Portolés A, et al. Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia. JAMA Network Open. 2025;8(8):e2526129. doi:10.1001/jamanetworkopen.2025.26129
BibTeX
@article{FernndezRomero2025,
author = {Fernández-Romero, Lucía and Cabrera-Martin, María Nieves and Delgado-Alonso, Cristina and Suárez-Coalla, Paz and Grasso, Stephanie M and Portolés, Antonio and Pérez-Macías, Natalia and Carreras, María Teresa and Díez-Cirarda, María and Gil-Moreno, María José and Olazarán, Javier and Vieira, Alba and Oliver-Mas, Silvia and Gómez-Pinedo, Ulises and Matías-Guiu, Jorge and Matias-Guiu, Jordi A},
title = {Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {8},
pages = {e2526129},
doi = {10.1001/jamanetworkopen.2025.26129}
}
EUVIMED